PAH News

March 20, 2020March 20, 2020

Orenitram Tablets More Cost-effective Than Uptravi as PAH Treatment, Study Suggests

News, PAH News

Treatment with Orenitram (oral treprostinil) is associated with lower healthcare-related costs than treatment with Uptravi (selexipag) in people with pulmonary arterial hypertension (PAH), a new study suggests. The study, “Medication Adherence ... Read more

March 11, 2020March 11, 2020

More PAH Cases in US Southwest than Registry Reports, Study Says

News, PAH News

The number of both new and existing cases of pulmonary arterial hypertension (PAH) in the southwestern U.S. population was found in a recent study to be higher than that ... Read more

March 6, 2020March 6, 2020

Mutations in BMPR2 Gene More Common in Men with PAH, Study Reports

News, PAH News

Men with pulmonary arterial hypertension (PAH) are more likely to carry mutations in the BMPR2 gene, a known genetic risk factor for PAH, a study from China found. Male ... Read more

March 4, 2020March 4, 2020

FDA Allows Specialty Pharmacies to Prefill Remodulin Into Remunity Pump

News, PAH News

The U.S. Food and Drug Administration (FDA) granted an extra clearance to the Unity Subcutaneous Delivery System for Remodulin (treprostinil) Injection, also known as the Remunity pump, allowing the system to be ... Read more

February 26, 2020February 26, 2020

Young PH Researchers Boosted by Foundation Partner Grants

News, PAH News, PH News

The ATS Foundation Research Program and Pulmonary Hypertension Association have announced the 2019 recipients of their partner grants, totaling $210,000, for young researchers dedicated to scientific discovery and better patient ... Read more

February 19, 2020February 19, 2020

Proteins Made on Lettuce Leaves May Lead to Safe and Less Costly PAH Treatment, Study Suggests

News, PAH News

Oral delivery of two proteins produced on lettuce leaves and involved in blood vessel health eased pulmonary hypertension and heart abnormalities in a rat model of pulmonary arterial hypertension ... Read more

February 17, 2020February 17, 2020

Case Report Suggests Lack of Vitamin C as PAH Cause

News, PAH News

Vitamin C deficiency can cause pulmonary arterial hypertension (PAH), a new case report suggests, highlighting the need to test vitamin C levels in people with PAH. The report, “Vitamin ... Read more

February 10, 2020February 10, 2020

Switching to Inhaled Treprostinil Combo Safe, Effective in Stable PAH Patients, Study Suggests

News, PAH News

Switching from injectable treprostinil or epoprostenol to a combination therapy including inhaled treprostinil appears to be safe, well tolerated, and effective for a select group of patients with clinically stable ... Read more

February 7, 2020February 7, 2020

PhaseBio Reports Positive Effects of PB1046 Therapy in PAH Patient in Case Study

News, PAH News

The biopharmaceutical PhaseBio announced positive results from a case study involving a patient with pulmonary arterial hypertension (PAH) who received treatment with PB1046, a new therapy using the company’s ... Read more

February 3, 2020February 6, 2020

FDA Asked to Approve LIQ861, Treprostinil Dry Powder Inhaler for PAH, Liquidia Announces

News, PAH News

Liquidia Technologies is requesting U.S. Food and Drug Administration (FDA) approval of LIQ861, an inhaled dry powder formulation of the vasodilator treprostinil, to treat pulmonary arterial hypertension (PAH). The request came in ... Read more

Pin It on Pinterest